argenx SE

Equities

ARGX

NL0010832176

Market Closed - Euronext Bruxelles Other stock markets 18:55:00 10/04/2026 +03			5-day change	1st Jan Change
682.00 ^EUR	+0.80%		+5.38%	-4.85%

04-07	European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading	MT
04-02	Oppenheimer Adjusts Price Target on Argenx to $1,014 From $1,060, Maintains Outperform Rating	MT

Transcript : Argenx SE Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08

Published on 06/10/2025 at 05:05 pm +03 - Modified on 06/10/2025 at 07:05 pm +03

S&P Capital IQ

Presenter Speech
Rajan Sharma (Analysts)

Good morning, everyone. My name is Rajan Sharma. I cover European pharma and biotech here at Goldman Sachs. I'm very pleased to have with us this morning, Karl

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about argenx SE

04-07	European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading	MT
04-02	Oppenheimer Adjusts Price Target on Argenx to $1,014 From $1,060, Maintains Outperform Rating	MT
04-01	ARGENX : UBS gives a Neutral rating	ZD
04-01	ARGENX : Goldman Sachs reaffirms its Buy rating	ZD
03-30	ARGENX : Receives a Buy rating from Barclays	ZD
03-20	Argenx SE Announces Retirement of Jim Daly as Non-Executive Director and Chair of the Commercialization Committee, Effective May 6, 2026	CI
03-14	How are different indices influenced?
03-11	Deutsche Bank Upgrades Argenx to Buy, Boosts PT	MT
03-06	Argenx SE Presents New Data and Pipeline Updates At 2026 AAN Annual Meeting	CI
03-05	European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading	MT
03-05	ARGENX : Gets a Buy rating from JP Morgan	ZD
02-27	RBC Capital Adjusts argenx SE ADR PT to $890 From $925, Maintains Outperform Rating	MT
02-27	Inflation Bites Back
02-27	ARGENX : Barclays remains its Buy rating	ZD
02-27	ARGENX : Goldman Sachs gives a Buy rating	ZD